The second phase of the Wuthering Waves 3.2 update is set to start on April 9, 2026, and will introduce a new set of content to the game. Phoebe and Lynae will receive their rerun banners during the ...

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

The General Services Administration has unveiled the first phase of awards under the Alliant 3 governmentwide acquisition contract, a multiple-award vehicle supporting federal IT modernization. The ...

Abstract: Distribution grids are facing a great transformation in recent years with the advent of smart grid technologies. Particularly, more and more controllable devices, based on power electronics, ...

The biggest stories of the day delivered to your inbox.

Both dosage regimens of amlitelimab were associated with statistically significant improvements in skin clearance and disease severity vs placebo in the US estimand. Topline data were announced from ...

Baumüller cooperates with ControlEng Corporation to have IPMSM motor model of the DS4 series integrated into sizing software SERVOsoft. The DS4 motor series features interior magnets, is very compact, ...

The secretary of state told lawmakers the administration has a three-phase plan for Venezuela after ousting its leader, including seizing oil and controlling the proceeds. By Robert Jimison Robert ...

Intellia Therapeutics has temporarily paused dosing and screening in a pair of phase 3 trials in response to a liver safety signal. Shares in Intellia fell 44% to $14.34 in early trading Monday. The ...

Cagrilintide was well-tolerated, with the most common side effects being gastrointestinal, including nausea, vomiting, diarrhoea and constipation. These were mainly temporary and mild to moderate.

The streaming platform is offering Veo 3—Google’s new AI video generator that’s giving game developers and filmmakers jitters—to normal users for making short videos starting Tuesday, along with other ...

Regeneron has reported a phase 3 win in generalized myasthenia gravis (gMG), positioning the pharma to file for FDA approval of its siRNA candidate in the increasingly competitive neuromuscular ...